HOME >> MEDICINE >> NEWS
Selective and nonselective beta-blockers equally effective in preventing sudden death

DALLAS - September 2, 1999 - A new study from UT Southwestern Medical Center at Dallas should encourage cardiologists to prescribe either selective or nonselective beta-blockers to patients with congestive heart failure. Researchers found both types of drugs equally effective in reducing the risk of sudden death.

In a study of 26 patients with congestive heart failure, researchers from UT Southwestern and Dallas Veterans Affairs Medical Center found no difference in the reduction of QTc dispersion -- a marker of risk for sudden death -- between those treated with selective beta-blockers and those treated with nonselective beta-blockers. Their findings were published in the August issue of The American Journal of Cardiology.

The scientists compared the electrocardiograms (ECG) of the patients before and after three months of therapy with either a selective beta-blocker, which inhibits the beta 1 receptor, or a nonselective beta-blocker, which inhibits both the beta 1 and the beta 2 receptors.

Congestive heart failure kills more than 43,000 people in the United States annually. A number of recent studies have shown that physicians underprescribe beta-blockers because of their side effects despite clinical-trial reports that congestive-heart-failure patients who take them are 43 percent less likely to die during the first two years following a first heart attack than those who do not take them. Side effects may include depression, worsening asthma, tiredness and sexual dysfunction, although many physicians note that the heart attack itself may produce these.

"This is significant because it gives us a better idea of how effective different beta-blockers are in treating congestive heart failure," said Dr. Eric Eichhorn, UT Southwestern professor of internal medicine and director of the cardiac catheterization laboratory at the VA Medical Center. "The findings give doctors more options in treating their patients and help us a
'"/>

Contact: Susan Steeves
susan.steeves@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
31-Aug-1999


Page: 1 2

Related medicine news :

1. Selective coatings create biological sensors from carbon nanotubes
2. Selective inhibitor can target specific enzyme that promotes cancer
3. In heart failure, beta-blockers boost survival advantage for women
4. Wider use of beta-blockers after heart attacks could save thousands of lives at a reasonable cost, new study shows
5. Aspirins potential ability to prevent colon polyps may not apply equally to all
6. New guidelines conclude all aerosol therapy devices equally effective
7. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix
8. Beta-blocker or calcium antagonist-based therapies equally effective in treating hypertension
9. Smoking cessation success equally good with over-the-counter or prescription nicotine replacement
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
(Date:9/2/2015)... ... ... article published August 12 by International Business Times, a new bill was signed ... in cases meant to decide if a police officer used deadly or excessive force in ... and New York City that absolved police officers of charges in the deaths of two ...
(Date:9/2/2015)... ... September 02, 2015 , ... Specifically, ... the news recently following a decision by the Centers for Medicare & Medicaid ... to average approximately $71,000 or roughly 40% of its headline-grabbing $178,000 price tag. ...
(Date:9/2/2015)... ... September 02, 2015 , ... RxNT , an ... of its enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone ... usability. A leader in health technology, RxNT was one of the first to ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... 2015 , ... A UPMC and University of Pittsburgh Schools ... a premier center for treatment of and research into hereditary hemorrhagic telangiectasia (HHT), ... , Cure HHT, previously known as The HHT Foundation International, has designated ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
(Date:9/2/2015)... --  Physicians Rx Pharmacy ("PRxP") today announced that ... as President and Chief Executive Officer.  Mr. ... Executive Officer for Soleo Health Specialty Infusion Services, will, ... Pharmacy, be responsible for leading the rapidly-growing 340B pharmacy ... bring Gaston on as the President and CEO of ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has ... (London, UK - November 19-20, 2015)" conference to ... will cover industry case studies, regulatory updates, latest therapies ... Dr Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar ...
Breaking Medicine Technology:Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2
Cached News: